Abattis Bioceuticals (Abattis Bioceuticals) Change In Payables And Accrued Expense : $6.12 Mil (TTM As of Sep. 2019)

View and export this data going back to . Start your Free Trial

What is Abattis Bioceuticals Change In Payables And Accrued Expense?

Abattis Bioceuticals's Change In Payables And Accrued Expense for the quarter that ended in Sep. 2019 was $-0.28 Mil. It means Abattis Bioceuticals's Accounts Payable & Accrued Expense declined by $0.28 Mil from Jun. 2019 to Sep. 2019 .

Abattis Bioceuticals's Change In Payables And Accrued Expense for the fiscal year that ended in Sep. 2019 was $6.14 Mil. It means Abattis Bioceuticals's Accounts Payable & Accrued Expense increased by $6.14 Mil from Sep. 2018 to Sep. 2019 .

Abattis Bioceuticals Change In Payables And Accrued Expense Historical Data

The historical data trend for Abattis Bioceuticals's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abattis Bioceuticals Change In Payables And Accrued Expense Chart

Abattis Bioceuticals Annual Data

Trend

Sep10

Sep11

Sep12

Sep13

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

0.34

-0.10

6.14

Abattis Bioceuticals Quarterly Data
	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-0.10	0.06	-0.04	6.38	-0.28

Abattis Bioceuticals Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Sep. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $6.12 Mil.

Abattis Bioceuticals Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Abattis Bioceuticals's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Abattis Bioceuticals (Abattis Bioceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abattis Bioceuticals Corp (OTCPK:ATTBF) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

1200 - 625 Howe Street, Vancouver, BC, CAN, V6C 2M6

Website

http://www.abattis.com

Abattis Bioceuticals Corp is a Canadian life science and biotechnology company focuses on aggregating, integrating and investing in agricultural technologies and biotechnology services for the legal cannabis industry. It is primarily engaged in producing, licensing and marketing proprietary ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The company is also engaged in growing, extraction, testing, propagation and online distribution.